The Indian Cancer Genome Atlas (ICGA) has launched India's first comprehensive cancer multi-omics data portal. This ...

BAY 2927088, an oral, reversible tyrosine kinase inhibitor (TKI) that potently inhibits mutant HER2, led to promising response rates when used for the treatment of patients with pretreated HER2 ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

The president will join the leaders of Australia, India and Japan to announce a new initiative for reducing cervical cancer ...

Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...

Researchers explore the global rise in early-onset cancers, linking environmental exposures and lifestyle changes to the ...

Chairs and presenters from the 2024 World Conference on Lung Cancer comment on their favorite parts about attending this ...

Researchers compared health-related quality of life with nivolumab added to first-line chemo vs chemo alone in patients with ...

ArriVent BioPharma is developing a treatment for non-small cell lung cancer. Click here to read more about AVBP stock and ...

France’s Sanofi has entered into an exclusive licensing agreement with US biotechnology company RadioMedix and French biotechnology company Orano ...

The principal goal of therapies for multiple myeloma, which remains incurable, is to extend progression-free survival, but challenges remain bringing chimeric antigen receptor T-cell therapy to the ...